Regenerative Medicine Inst is categorized under Health Services in Chula Vista, CA and active since 2011.
Regenerative Medicine Inst was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 8139100 by the NAICS.
If you are seeking more information, feel free to contact Keith March at the company’s single location by writing to 2829 Paradise Ridge Court, Chula Vista, California CA 91915 or by phoning (619) 421-0700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Regenerative Medicine Inst |
| Contact Person: | Keith March |
| Address: | 2829 Paradise Ridge Court, Chula Vista, California 91915 |
| Phone Number: | (619) 421-0700 |
| Website Address: | regenerativemedicine.mx |
| Annual Revenue (USD): | Unknown |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 8139100 |
| Share This Business: |
Regenerative Medicine Inst was started in 2011 to provide professional Health Services under the SIC code 8099 and NAICS code 8139100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Keith March for inquiries that concern Regenerative Medicine Inst by calling the company number (619) 421-0700, as your correspondence is most welcome. Additionally, the physical location of the single location of Regenerative Medicine Inst can be found at the coordinates 32.642635,-116.939017 as well as the street address 2829 Paradise Ridge Court in Chula Vista, California 91915.
For its online presence, you may visit Regenerative Medicine Inst’s website at regenerativemedicine.mx and engage with its social media outlets through on Twitter and on Facebook.